Literature DB >> 8783400

Transient perfusion and radiosensitizing effect after nicotinamide, carbogen, and perflubron emulsion administration.

C D Thomas1, S Stern, D J Chaplin, M Guichard.   

Abstract

In order to improve the effect of radiation on tumour response, nicotinamide, perflubron emulsion and carbogen were administered which act on both diffusion limited hypoxia and intermittent perfusion limited hypoxia. These treatments were used in different combinations. The maximal radiosensitizing effect was found with the combination of the three treatments. The aim of this study was to use a double staining method (Hoechst 33342 and DiOC7(3) to evaluate the influence of nicotinamide, perflubron emulsion and carbogen on transient perfusion in three tumour cell lines transplanted onto nude mice: one rodent (EMT6), two human (HRT18, a rectal adenocarcinoma; and Na11+, a melanoma). For untreated groups, the percentage of closed and mismatched vessels depended on the tumour cell line. Carbogen alone or carbogen plus perflubron emulsion decreased the number of mismatched and closed vessels only for the two human cell lines. Nicotinamide was effective in decreasing the percentage of mismatched and closed vessels only for the melanoma cell line. The combination of nicotinamide, carbogen and perflubron emulsion was the most effective at decreasing both percentage of mismatched and closed vessels in all three tumours studies. This combination was also the most effective at enhancing the radiation response in all three tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783400     DOI: 10.1016/0167-8140(96)01734-3

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Skin oxygenation after topical application of liposome-entrapped benzyl nicotinate as measured by EPR oximetry in vivo: influence of composition and size.

Authors:  Julijana Kristl; Zrinka Abramović; Marjeta Sentjurc
Journal:  AAPS PharmSci       Date:  2003

2.  Microvascular Perfusion Changes following Transarterial Hepatic Tumor Embolization.

Authors:  Carmen Gacchina Johnson; Karun V Sharma; Elliot B Levy; David L Woods; Aaron H Morris; John D Bacher; Andrew L Lewis; Bradford J Wood; Matthew R Dreher
Journal:  J Vasc Interv Radiol       Date:  2015-08-28       Impact factor: 3.464

3.  Vasoactivity of AG014699, a clinically active small molecule inhibitor of poly(ADP-ribose) polymerase: a contributory factor to chemopotentiation in vivo?

Authors:  Majid Ali; Brian A Telfer; Cian McCrudden; Martin O'Rourke; Huw D Thomas; Marzieh Kamjoo; Suzanne Kyle; Tracy Robson; Chris Shaw; David G Hirst; Nicola J Curtin; Kaye J Williams
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

Review 4.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

Review 5.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response.

Authors:  Mark W Dewhirst; Yiting Cao; Benjamin Moeller
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

6.  Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

Authors:  H Wildiers; G Guetens; G De Boeck; E Verbeken; B Landuyt; W Landuyt; E A de Bruijn; A T van Oosterom
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.